Clinical Trial Update: AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update showing results for Amgen’s AMG 757 and AMG 404 in Small Cell Lung Cancer; results were posted in October 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• AMG 404
• AMG 757

Snippet

Sponsor: Amgen | Conditions: Small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-10-15